Aurora Cannabis ACB shares are trading higher after the company provided a progress update on its previously announced "Business Transformation Plan."
The company said it will exit 2020 at a selling, general & administrative run rate of roughly $42 million and it remains on track for positive adjusted EBITDA in the first quarter of 2021.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 25 countries.
Aurora Cannabis was trading 5.2% higher to $14.42 at the time of publication on Tuesday. The stock has a 52-week high of $95.76 and a 52-week low of $5.30.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.